We are live on ! Find out more
SRXH

SRX Global

1.73 USD
+0.03
1.76%
At close Updated Sep 24, 4:00 PM EDT
Pre-market
After hours
1.77
+0.04
2.31%
1 day
1.76%
5 days
5.49%
1 month
-4.42%
3 months
-4.95%
6 months
-76.24%
Year to date
-87.88%
1 year
-91.76%
5 years
-99.98%
10 years
-99.98%
 

About: SRX Global Inc is an AI-driven platform focused on investing in operating companies, strategic assets, and technology-enabled opportunities across multiple sectors. It uses technology and data analytics to identify and manage investments.

Employees: 11

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
GlobeNewsWire
14 hours ago
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones for facial recognition to body cameras. SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones for facial recognition to body cameras.
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
Neutral
GlobeNewsWire
1 day ago
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
NORTH PALM BEACH, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that SRX Global's CEO, Kent Cunningham, and President, EMJX Platform and Head of Asset Management, Eric Jackson, will present at the Webull Corporate Connect Series Fintech Investment Webinar, a live investor webinar hosted on the Webull platform, on September 30, 2026.
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
Neutral
GlobeNewsWire
21 days ago
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
NORTH PALM BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today is providing shareholders with an update on its portfolio company ARMR Sciences (“ARMR”), a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl, from its CEO, Collin Gage.
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
Neutral
GlobeNewsWire
24 days ago
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
The Debt investment is expected to accelerate development of CERo's lead therapeutic CER-1236 for hematological cancers The Debt investment is expected to accelerate development of CERo's lead therapeutic CER-1236 for hematological cancers
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
Neutral
GlobeNewsWire
1 month ago
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
Net Asset Value ("NAV") of  $62.9 million , or $3.22 per Common Share, Exceeding Preliminary Estimate of $3.07 per Share 1 Ended the Quarter with $36.7 million of Cash, Cash Equivalents and Restricted Cash, $65.2 million in Current Assets, and $2.4 million in Total Liabilities, With No Debt Outstanding Adjusted EBITDA Loss Improved 35% year over year to $1.6 million 4 Strengthened Halo Operations, Exiting the Quarter with 98% Fill Rates and Record Prime Day Performance NORTH PALM BEACH, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced its financial results for the fiscal third quarter ended June 30, 2026.
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
Neutral
GlobeNewsWire
1 month ago
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
NORTH PALM BEACH, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it plans to host a conference call and report its financial results for the fiscal third quarter ended June 30, 2026, on Thursday, August 13, 2026.
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
Neutral
GlobeNewsWire
1 month ago
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it has acquired a stake in Vistagen Therapeutics, Inc. (Vistagen) (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines.
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
Neutral
GlobeNewsWire
1 month ago
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
NORTH PALM BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, strengthening its critical minerals sourcing.
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
Neutral
GlobeNewsWire
1 month ago
SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering
NORTH PALM BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it acquired shares in the initial public offering of Jersey Mike's, a leading fast-casual restaurant franchisor with more than 3,300 locations across the United States and Canada, which priced its Class A common shares at $23.00 per share yesterday at a total valuation of $1 billion and began trading on the New York Stock Exchange today under the ticker JMKE.
SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering
Neutral
GlobeNewsWire
2 months ago
SRX Global Regains Full Compliance with NYSE American Listing Standards
Company Resolves Section 1003(a)(i) and (ii) Deficiencies; Compliance Indicator to Be Removed Company Resolves Section 1003(a)(i) and (ii) Deficiencies; Compliance Indicator to Be Removed
SRX Global Regains Full Compliance with NYSE American Listing Standards
Price charts implemented using Lightweight Charts™